277 related articles for article (PubMed ID: 32466117)
1. In Vitro Activity of Essential Oils Against Planktonic and Biofilm Cells of Extended-Spectrum β-Lactamase (ESBL)/Carbapenamase-Producing Gram-Negative Bacteria Involved in Human Nosocomial Infections.
Iseppi R; Di Cerbo A; Aloisi P; Manelli M; Pellesi V; Provenzano C; Camellini S; Messi P; Sabia C
Antibiotics (Basel); 2020 May; 9(5):. PubMed ID: 32466117
[TBL] [Abstract][Full Text] [Related]
2. Essential Oils: A Natural Weapon against Antibiotic-Resistant Bacteria Responsible for Nosocomial Infections.
Iseppi R; Mariani M; Condò C; Sabia C; Messi P
Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33920237
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Synergistic Potency of Essential Oils and Antibiotics Against Klebsiella pneumoniae BLSE Strains.
Bariz K; Trabelsi L; Lahcene S; Salem-Bekhit MM; Elossaily GM; Ali Alzahrani H; Alharbi OO; Abbaci M; Abbaci H; Benguerba Y; Houali K
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):198-206. PubMed ID: 37300667
[TBL] [Abstract][Full Text] [Related]
4. Effects of
Iseppi R; Mariani M; Benvenuti S; Truzzi E; Messi P
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838657
[TBL] [Abstract][Full Text] [Related]
5. Activity of Liquid and Volatile Fractions of Essential Oils against Biofilm Formed by Selected Reference Strains on Polystyrene and Hydroxyapatite Surfaces.
Dudek-Wicher R; Paleczny J; Kowalska-Krochmal B; Szymczyk-Ziółkowska P; Pachura N; Szumny A; Brożyna M
Pathogens; 2021 Apr; 10(5):. PubMed ID: 33922823
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activities of essential oils from Iranian medicinal plants on extended-spectrum β-lactamase-producing Escherichia coli.
Sharifi-Rad J; Mnayer D; Roointan A; Shahri F; Ayatollahi SA; Sharifi-Rad M; Molaee N; Sharifi-Rad M
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(9):75-82. PubMed ID: 27650980
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Primary Action Mode of Eight Essential Oils and Evaluation of Their Antibacterial Effect against Extended-Spectrum β-Lactamase (ESBL)-Producing
Aouadhi C; Jouini A; Mechichi D; Boulares M; Hamrouni S; Maaroufi A
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458786
[TBL] [Abstract][Full Text] [Related]
8. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal.
Nepal K; Pant ND; Neupane B; Belbase A; Baidhya R; Shrestha RK; Lekhak B; Bhatta DR; Jha B
Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):62. PubMed ID: 28927454
[TBL] [Abstract][Full Text] [Related]
9. [The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures].
Baykal A; Cöplü N; Simşek H; Esen B; Gür D
Mikrobiyol Bul; 2012 Apr; 46(2):159-69. PubMed ID: 22639305
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Ability to Form Biofilms in KPC-Producing and ESBL-Producing
Sabença C; Costa E; Sousa S; Barros L; Oliveira A; Ramos S; Igrejas G; Torres C; Poeta P
Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508239
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of clove (
Ginting EV; Retnaningrum E; Widiasih DA
Vet World; 2021 Aug; 14(8):2206-2211. PubMed ID: 34566340
[TBL] [Abstract][Full Text] [Related]
12. Spreading of extended-spectrum β-lactamase-producing Escherichia coli ST131 and Klebsiella pneumoniae ST11 in patients with pneumonia: a molecular epidemiological study.
Liu J; Du SX; Zhang JN; Liu SH; Zhou YY; Wang XR
Chin Med J (Engl); 2019 Aug; 132(16):1894-1902. PubMed ID: 31408445
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
Liao K; Chen Y; Wang M; Guo P; Yang Q; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Xu Y
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):45-48. PubMed ID: 27773544
[TBL] [Abstract][Full Text] [Related]
17. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Xiong Z; Zhu D; Zhang Y; Wang F
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
[TBL] [Abstract][Full Text] [Related]
18. Preliminary Study on the Antibacterial Activity of Essential Oils Alone and in Combination with Gentamicin Against Extended-Spectrum β-Lactamase-Producing and New Delhi Metallo-β-Lactamase-1-Producing Klebsiella pneumoniae Isolates.
Kwiatkowski P; Pruss A; Grygorcewicz B; Wojciuk B; Dołęgowska B; Giedrys-Kalemba S; Kochan E; Sienkiewicz M
Microb Drug Resist; 2018 Nov; 24(9):1368-1375. PubMed ID: 29708847
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
Kao CY; Udval U; Huang YT; Wu HM; Huang AH; Bolormaa E; Yan JJ; Urangoo Z; Batbaatar G; Khosbayar T; Wu JJ
J Microbiol Immunol Infect; 2016 Oct; 49(5):692-700. PubMed ID: 26194952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
